WallStreetZenWallStreetZen

NASDAQ: LYRA
Lyra Therapeutics Inc Stock Ownership - Who owns Lyra Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Lyra Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Edward T. AndersonDirector2023-05-311,203,612$2.43
$2.92MBuy
Edward T. AndersonDirector2023-05-31197,946$2.43
$481.01kBuy
Edward T. AndersonDirector2023-05-31403,858$2.43
$981.37kBuy
Nbvm GP LLC10% Owner2023-05-311,203,612$2.43
$2.92MBuy
Nbvm GP LLC10% Owner2023-05-31197,946$2.43
$481.01kBuy
Nbvm GP LLC10% Owner2023-05-31403,858$2.43
$981.37kBuy
Perceptive Advisors LLCDirector2023-05-313,610,832$2.49
$9.00MBuy

1 of 1

LYRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LYRA insiders and whales buy or sell their stock.

LYRA Shareholders

What type of owners hold Lyra Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC25.75%12,757,562$46.82MInstitution
Armistice Capital LLC8.10%4,012,036$14.72MInstitution
Nantahala Capital Management LLC7.99%3,957,542$14.52MInstitution
Citadel Advisors LLC5.75%2,849,178$10.46MInstitution
Samsara Biocapital LLC5.61%2,780,261$10.20MInstitution
Edward T. Anderson5.33%2,640,228$9.69MInsider
Perceptive Advisors LLC5.20%2,576,892$9.46MInsider
Nbvm GP LLC5.09%2,521,745$9.25MInsider
Pura Vida Investments LLC2.85%1,413,242$5.19MInstitution
Ikarian Capital LLC1.98%978,626$3.59MInstitution

1 of 3

LYRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYRA68.02%16.86%Net Buying
LRMR43.87%56.13%Net Buying
ATRA88.76%8.36%Net SellingNet Selling
IFRX31.50%0.00%
GOSS27.52%14.43%Net BuyingNet Buying
View Top Biotech Stocks

Lyra Therapeutics Stock Ownership FAQ

Who owns Lyra Therapeutics?

Lyra Therapeutics (NASDAQ: LYRA) is owned by 68.02% institutional shareholders, 16.86% Lyra Therapeutics insiders, and 15.13% retail investors. Edward T. Anderson is the largest individual Lyra Therapeutics shareholder, owning 2.64M shares representing 5.33% of the company. Edward T. Anderson's Lyra Therapeutics shares are currently valued at $9.69M.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.